Bovine respiratory disease (BRD) is the most common and costly disease affecting beef cattle in the world. BRD in cattle caused by a range of factors, singly or in combination. A major cause of economic losses, BRD affects the lower respiratory tract / lungs (pneumonia) or upper respiratory tract (rhinitis, tracheitis, bronchitis). It is a complex, bacterial infection that causes pneumonia in calves and can possibly be fatal. The infection is usually a sum of three codependent factors: Stress, an underlying viral infection, and a new bacterial infection. BRD is a “multi-factorial syndrome” that is dependent on a number of different causes. The bacterial agents most commonly linked with BRD are Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma bovis. Viral agents include Bovine Viral Diarrhea (BVD), Infectious Bovine Rhinotracheitis (IBR), Bovine Respiratory Synctial Virus (BRSV), and Parainfluenza Type-3 Virus (PI-3). Antibiotics such as Micotil, Nuflor, and Baytril 100, Naxcel, Excenel, and Adspec can help to stop the bacterial factors of the disease. Vaccines are available for a number of viral/bacterial agents, including IBR, PI3, BVD, BRSV, Pasteurella, and Haemophilius somnus. Banamine is an anti-inflammatory drug which helps reduce fever and damage to the lungs, and therefore may help sick calves get back on feed quicker. Vitamin B and Probiotics can be used to help stimulate appetite.
The global bovine respiratory disease treatment market segmentation is based on disease type (diphtheria, pneumonia/lower respiratory tract infection, upper respiratory tract infections), treatment type (antibiotics, immunomodulators, NSAIDs, vaccines, others), and end users (private veterinary pharmacies, veterinary clinics, veterinary hospitals, veterinary research institutes, others).
The global bovine respiratory disease treatment market report provides market size (Revenue US$ Million 2014 to 2021), market share, trends and forecasts growth trends (CAGR%, 2017 to 2021). The global bovine respiratory disease treatment market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global bovine respiratory disease treatment market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market by company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market.
Major players operating in the global bovine respiratory disease treatment market and included in this report are Bayer AG, Bimeda Animal Health, Boehringer Ingelheim GmbH, Ceva, Elanco, Merck & Co., Inc., Merial, Vetoquinol, Virbac Group, and Zoetis Services LLC.